AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009
Feb 26, 2009
30339_dirs_2009-02-26_ea70cc25-58b0-42cf-8fc4-858175e2acc2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24
Reporting Person: FEDERICI WILLIAM J (VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-02-24 | Common Stock | A | 4050 | $32.09 | Acquired | 61322.2045 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-02-24 | Stock Option (Right to Buy) | $32.09 | A | 26000 | Acquired | 2019-02-24 | Common Stock (26000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 472.832 | Indirect |
| Common Stock | 15776.7373 | Indirect |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.
F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27